Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) in a research report issued on Monday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, Alliance Global Partners started coverage on Aptevo Therapeutics in a research note on Monday, October 9th. They set a “buy” rating […]

Leave a Reply

Your email address will not be published.

Previous post Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Upgraded by StockNews.com
Next post Citigroup Initiates Coverage on Afya (NASDAQ:AFYA)